EGFR and neoplasm: For example, EGFR overexpression upregulates key markers of M2 macrophages, including STAT6, CD163, and MRC1, which negatively affects tumor-infiltrating lymphocytes and promotes resistance to cetuximab, an EGFR-specific antibody [73].